110 related articles for article (PubMed ID: 12520749)
1. [Comparison of NP and MVP regimen in treatment of advanced non-small cell lung cancer].
Qiang E; Wang SP; Liu SJ; Yiao J
Ai Zheng; 2002 Dec; 21(12):1362-4. PubMed ID: 12520749
[TBL] [Abstract][Full Text] [Related]
2. [Prospective randomized study of HMVP, MVP, and HVP regimens in treatment of advanced non-small cell lung cancer].
Gao JF; Li CS; Zhang BC; Du GZ; Zhang XH; Wang J; Zhu YZ; Ou WL; Yang B
Ai Zheng; 2004 Apr; 23(4):435-8. PubMed ID: 15087034
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of treatment efficacy of the second and the third generations of chemoradiotherapy regimens containing platinum on advanced non-small cell lung cancer].
Wang YM; Guo LJ; Li LS; Li P; Zheng J; Li L
Ai Zheng; 2005 Dec; 24(12):1514-7. PubMed ID: 16351804
[TBL] [Abstract][Full Text] [Related]
4. [Mitomycin, vindesine and cisplatin combination therapy in the treatment of advanced non-small cell lung cancer: a report of 108 cases].
Zhang X; Sun Y; Feng F
Zhonghua Zhong Liu Za Zhi; 1999 May; 21(3):220-3. PubMed ID: 11776842
[TBL] [Abstract][Full Text] [Related]
5. [Combination chemotherapy with Taxol and cisplatin for 57 patients with non-small cell lung cancer by intraartery and intravenous infusion].
Zhao Y; Wang SM; Zhang J
Ai Zheng; 2002 Dec; 21(12):1365-7. PubMed ID: 12520750
[TBL] [Abstract][Full Text] [Related]
6. [A comparative study between clinical response and pathologic changes to preoperative chemotherapy in non-small cell lung cancer].
Lu S; Liao M; Lin Z
Zhonghua Zhong Liu Za Zhi; 1999 Sep; 21(5):366-8. PubMed ID: 11776576
[TBL] [Abstract][Full Text] [Related]
7. [Clinical study of combination chemotherapy with mitomycin C, vindesine and cisplatin (MVP therapy) in advanced non-small cell lung cancer].
Setoguchi J; Sawada M; Onodera H; Sigeta M; Nakai M; Nakano K; Kanatsuna T; Kondoh M; Hotta T; Hayashi H
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2399-403. PubMed ID: 2546504
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of combined chemotherapy including high-dose cisplatin in the treatment of malignant tumors].
Zhou JC; Feng FY; Sun Y; Wang QL; Zeng WY; Liu YY
Zhonghua Zhong Liu Za Zhi; 1987 Mar; 9(2):136-9. PubMed ID: 2820683
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC.
Lena MD; Ramlau R; Hansen O; Lorusso V; Wagner L; Barni S; Cristovao MM; Huber R; Alberola V; Mitrovic M; Colin C; Gasmi J
Lung Cancer; 2005 Apr; 48(1):129-35. PubMed ID: 15777980
[TBL] [Abstract][Full Text] [Related]
10. [Comparative study of three different chemotherapy protocols for advanced non-small-cell lung cancer].
Chen L; Wang J; Chu X
Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):151-2. PubMed ID: 11776862
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of a biweekly regimen of vinorelbine and cisplatin in advanced non-small cell lung cancer.
Chen CH; Lin CM; Kao KC; Chang JW; Tsao TC
Chang Gung Med J; 2007; 30(3):249-55. PubMed ID: 17760276
[TBL] [Abstract][Full Text] [Related]
12. Vinorelbine plus cisplatin versus cisplatin plus vindesine and mitomycin C in stage IIIB-IV non-small cell lung carcinoma: a prospective randomized study.
Gebbia V; Galetta D; Riccardi F; Gridelli C; Durini E; Borsellino N; Gebbia N; Valdesi M; Caruso M; Valenza R; Pezzella G; Colucci G;
Lung Cancer; 2002 Aug; 37(2):179-87. PubMed ID: 12140141
[TBL] [Abstract][Full Text] [Related]
13. Do the time to chemotherapy response and the dose intensity have an impact on patient outcome in advanced non-small cell lung cancer?
Radosavljevic D; Golubicic I; Gavrilovic D; Kezic I; Jelic S
J BUON; 2009; 14(2):203-9. PubMed ID: 19650167
[TBL] [Abstract][Full Text] [Related]
14. [Nadaplatin or cisplatin combined with paclitaxol in treatment for non-small cell lung cancer: a randomized controlled study].
Chen LK; Xu GC; Guan ZZ; Hang Y; Yang QY
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):437-40. PubMed ID: 17974278
[TBL] [Abstract][Full Text] [Related]
15. [Activity of toremifene plus mitomycin, vindesin and cisplatin regimen in unresectable non-small cell lung cancer].
Zhou CC; Zhang J; Zheng D; Lu MJ; Lu B; Xu JF
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Aug; 27(8):546-8. PubMed ID: 15388005
[TBL] [Abstract][Full Text] [Related]
16. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study.
Zatloukal P; Petruzelka L; Zemanova M; Havel L; Janku F; Judas L; Kubik A; Krepela E; Fiala P; Pecen L
Lung Cancer; 2004 Oct; 46(1):87-98. PubMed ID: 15364136
[TBL] [Abstract][Full Text] [Related]
17. [Comparision of high dose impulsion and low dose density chemotherapeutic regimens with paclitaxel plus cisplatin in advanced NSCLC].
Hua XM; Ren XW; Liu FL; Liu Y; Zhang CJ; Li ZJ; Xu L; Liu JY; Liu YG
Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):621-5. PubMed ID: 15634526
[TBL] [Abstract][Full Text] [Related]
18. [Symptomatic treatment versus combination chemotherapy in advanced non-small cell lung cancer].
Xu G; Liu G
Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):60-2. PubMed ID: 11776801
[TBL] [Abstract][Full Text] [Related]
19. Randomized study of maintenance vinorelbine in responders with advanced non-small-cell lung cancer.
Westeel V; Quoix E; Moro-Sibilot D; Mercier M; Breton JL; Debieuvre D; Richard P; Haller MA; Milleron B; Herman D; Level MC; Lebas FX; Puyraveau M; Depierre A;
J Natl Cancer Inst; 2005 Apr; 97(7):499-506. PubMed ID: 15812075
[TBL] [Abstract][Full Text] [Related]
20. [A randomized trial with various combinations of cis-platinum (CDDP), mitomycin C (MMC), peplomycin (PEP) and ftorafur (FT) in the treatment of non-small cell lung cancer].
Nakabayashi T; Yasuda S; Miyamoto H; Abe S; Ohosaki Y
Gan To Kagaku Ryoho; 1986 Oct; 13(10):2998-3004. PubMed ID: 2429619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
